Chronicle Journal: Finance

Sono-Tek Reports Record Sales and Backlog for Third Quarter Fiscal 2020

Record Sales of $3.67M, Up 16% Year-over-Year, and Backlog of $5.4M

MILTON, NY - (NewMediaWire) - January 14, 2020 - Sono-Tek Corporation (OTCQX: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fiscal 2020 third quarter and year-to-date period ended November 30, 2019.

Third Quarter Fiscal 2020 Financial Highlights:

  • Another Record Breaking Quarter for Sales of $3.67 million, a 16% increase compared to third quarter FY2019
  • Record high backlog of $5.40 million
  • Gross margin of 48.9% compared to 41.0% in third quarter FY2019, a 790 basis point expansion
  • Net income of $280,000 versus $20,000 in third quarter FY2019, a 14-fold increase
  • Sales Growth Guidance for FY2020 remains at 15% – 25% annual increase

Dr. Christopher L. Coccio, Chairman and CEO, commented, “For the third quarter, Sono-Tek reported another record breaking quarter and achieved new highs in sales, backlog, margins and net income. These gains stem from the strategic shift in our business model that we initiated several years ago, expanding our product line to provide higher value complete machine solutions and larger subsystems to original equipment manufacturers (“OEMs”). These product advancements are supported by a high level of application engineering expertise from our specialized staff, in combination with customer requirements that are proven out in our globally located process development labs. We have also invested significant resources to enhance our market diversity.”

“These shifts have improved our balance sheet, increased our financial strength and continue to drive interest in our expanding line of products. In addition, average unit selling prices have expanded to over $300 thousand per unit from $50 thousand per unit, a six-fold increase. To support the strong sales momentum, we are in the process of expanding our manufacturing facility and have acquired new machinery to accommodate Sono-Tek’s expected growth in the years ahead.”

Third Quarter FY2020 Financial Overview

For the third quarter of fiscal 2020 ended November 30, 2019, net sales were $3,672,000, an increase of 16%, or $517,000, compared to the third quarter of fiscal 2019. These results were primarily driven by increased sales for widetrack integrated coating systems in the float glass market and increased sales of the SonoBraze product for the manufacturing of heat exchangers and condensers for the automotive market.                             

The Company’s sales growth was particularly strong in the Medical market, which increased 68% in the third quarter and the Electronics/Microelectronics market, primarily semiconductor related, which increased 7%. The Company’s strategy of providing paid coating services as a part of its Application Engineering services, in addition to its coating equipment, has contributed to these increases.

In the third quarter of fiscal 2020, approximately 65% of sales originated outside of the United States and Canada, compared with 62% in the prior year period. The increase in export sales is primarily related to a larger custom medical device coating platform sold into Latin America.

Backlog on November 30, 2019 reached a new record level of $5,402,000, an increase of 78%, compared with backlog of $3,038,000 on February 28, 2019.

Gross profit increased $501,000, or 39%, to $1,797,000 for the third quarter of fiscal 2020 compared with $1,296,000 in the prior year period.  Gross profit margin was 48.9%, compared with 41.1% in the prior year period, an expansion of 790 basis points. The improvement in gross profit and margin for the third quarter is partially due to a shift in sales to countries other than China. The shift of sales away from China has reduced the deep discounts required to sell in China as well as the avoidance of tariffs, which have previously had a negative impact on margins. In the prior fiscal year period, the Company’s gross profit margin was negatively impacted due to a pricing strategy to establish a foothold in the fuel cell market in China.  In addition, a change in product mix benefited gross profit margins. This resulted from increased sales of widetrack systems and medicoat stent coating equipment, both of which have traditionally had higher profit margins compared to other Sono-Tek products.

Operating expenses totaled $1,527,000 in the current period, an increase of 23%, or $281,000, compared to the prior year period. Sono-Tek continues to invest in research and development and sales and marketing development activities. Commission expense doubled in the third quarter due to an increase in international revenue generated by the Company’s external distributors, which receive a higher rate than the Company’s internal sales team. 

Operating income increased $220,000, to $270,000, in the third quarter of fiscal 2020, compared with $50,000 for the prior year period. Growth in revenue and gross profit were key factors in the improvement of operating income. The operating margin for the third quarter increased to 7.4% compared with 1.6% in the prior year period. 

Net income for the fiscal third quarter was approximately $280,000, or $0.02 per share, compared with net income of approximately $20,000, or $0.00 per share, for the prior year period. Diluted weighted average shares outstanding totaled 15,371,819 compared to 15,386,094 for the prior year period.

First Nine Months FY2020 Financial Overview

For the first nine months of fiscal 2020, net sales increased to $9,841,000, an increase of 13%, or $1,167,000, led by a large increase in sales to the semiconductor industry, increased sales of stent coating systems, and increased sales of float glass coating equipment. Gross profit margin was 47.2% compared with 45.1% in the prior year period.  The gross margin expansion is primarily due to a shift in sales to countries other than China and a continuing positive change in product mix.  Operating income increased to $367,000 compared with $96,000 in the prior year period, primarily due to the growth in revenue and gross profit.  Operating margin for the first nine months of fiscal 2020 increased to 3.7% compared with 1.1% in the prior year period.  Net income for the nine months ended November 30, 2019 was approximately $420,000, or $0.03 per share, compared with net income of approximately $101,000 or $0.01 per share, for the prior year period. Diluted weighted average shares outstanding totaled 15,354,472 compared to 15,284,071 for the prior year period.

Balance Sheet and Cash Flow Overview

Cash and cash equivalents and short-term investments at quarter-end were $6.0 million, up from $5.5 million at the end of fiscal 2019.  The increase was the result of increased accounts payable, accrued expenses, customer deposits and a decrease in accounts receivable.  These sources of cash were partially offset by increased inventories, capital expenditures and debt repayments.

The increase in inventories since February 28, 2019, the end of the last fiscal year, of $1.3 million, is related to several large customer projects and supported by the increase in customer deposits of $0.8 million and the record $5.40 million in backlog.

Year-to-date capital expenditures were $392,000 compared with $487,000 in the prior-year period.  The increase was primarily due to investments to upgrade the Company’s manufacturing facilities.  The Company anticipates capital expenditures will total approximately $0.5 million to $0.6 million for FY2020.

At November 30, 2019, the Company had total debt of $749,000, down approximately $122,000 since fiscal 2019 year-end.  Long-term debt is solely comprised of the mortgage on the Company’s industrial park complex and has an interest rate of 4.15%.

Fiscal Year 2020 Outlook

“We expect that a significant portion of our $5.4 million backlog will ship during the current fiscal year ending February 29, 2020, assuming customer acceptance test schedules for some of the more complex and customized equipment orders.  Therefore, based on this existing backlog, we expect that net sales will increase 15% to 25% for the full fiscal year of 2020.  The increased sales volume is also expected to continue to positively impact margins and drive stronger earnings growth,” concluded Dr. Coccio.

About Sono-Tek

Sono-Tek Corporation is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.

The Company’s solutions are environmentally-friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

Sono-Tek’s growth strategy is focused on leveraging its innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for its customers’ products and processes.  For further information, visit

Safe Harbor Statement

This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products, including the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; maintenance of increased order backlog; consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the medical and alternative energy markets; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.

For more information, contact:

Stephen J. Bagley
Chief Financial Officer
Sono-Tek Corporation

Investor Relations:
Stephanie Prince
PCG Advisory
(646) 762-4518


  November 30,    
  2019  February 28, 
  (Unaudited)  2019 
Current Assets:      
Cash and cash equivalents $2,279,506  $3,144,123 
Marketable securities  3,739,935   2,365,706 
Accounts receivable (less allowance of $46,000)  1,338,320   1,397,891 
Inventories, net  2,978,780   1,658,016 
Prepaid expenses and other current assets  193,552   395,005 
Total current assets  10,530,093   8,960,741 
Land  250,000   250,000 
Buildings, net  1,673,275   1,731,547 
Equipment, furnishings and building improvements, net  975,835   802,932 
Intangible assets, net  110,453   122,941 
Deferred tax asset  332,017   332,017 
TOTAL ASSETS $13,871,673  $12,200,178 
Current Liabilities:        
Accounts payable $919,455  $585,694 
Accrued expenses  767,971   632,706 
Customer deposits  1,953,826   1,149,558 
Current maturities of long term debt  167,929   162,816 
Income taxes payable  24,744   6,272 
Total current liabilities  3,833,925   2,537,046 
Deferred tax liability  370,757   370,757 
Long term debt, less current maturities  581,065   707,715 
Total liabilities  4,785,747   3,615,518 
Commitments and Contingencies  (Note 10)      
Stockholders’ Equity        
Common stock, $.01 par value; 25,000,000 shares authorized, 15,323,831 and 15,197,563 shares issued and outstanding, at November 30 and February 28, respectively  153,238   151,976 
Additional paid-in capital  9,009,979   8,929,607 
Accumulated deficit  (77,291)  (496,923)
Total stockholders’ equity  9,085,926   8,584,660 


  Nine Months Ended
November 30,
  Three Months Ended
November 30,
  2019  2018  2019  2018 
Net Sales $9,840,536  $8,673,849  $3,672,286  $3,155,258 
Cost of Goods Sold  5,191,929   4,761,919   1,875,606   1,858,970 
Gross Profit  4,648,607   3,911,930   1,796,680   1,296,288 
Operating Expenses                
Research and product development costs  1,020,299   978,733   361,429   324,969 
Marketing and selling expenses  2,326,115   1,979,365   849,419   652,664 
General and administrative costs  935,693   857,832   316,218   268,632 
Total Operating Expenses  4,282,107   3,815,930   1,527,066   1,246,265 
Operating Income  366,500   96,000   269,614   50,023 
Interest Expense  (25,465)  (30,501)  (8,000)  (9,684)
Interest and Dividend Income  77,496   104,686   20,513   33,164 
Realized gain on sale of marketable securities     119,075       
Net unrealized loss on marketable securities     (189,016)     (59,359
Other income  24,404   28,196   7,527   8,681 
Income Before Income Taxes  442,935   128,440   289,654   22,825 
Income Tax Expense  23,303   27,627   10,000   2,566 
Net Income $419,632  $100,813  $279,654  $20,259 
Basic Earnings Per Share $0.03  $0.01  $0.02  $0.00 
Diluted Earnings Per Share $0.03  $0.01  $0.02  $0.00 
Weighted Average Shares - Basic  15,291,968   15,078,933   15,306,008   15,164,440 
Weighted Average Shares - Diluted  15,354,472   15,284,071   15,371,819   15,386,094
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.